Session: Respiratory Infections (IDWeek 2013)

887

Comparing Clinical Characteristics Between Hospitalized Adults With Laboratory-confirmed Influenza A and B Virus Infection, 2005-2012
Su Su, MSc, MPH ; Sandra Chaves, MD, MSc ; Alejandro Perez, MPH ; Tiffany D'mello, MPH, MBA ; Pam Daily, MPH ; Lisa Miller, MD, MSPH ; Kimberly Yousey-Hindes, MPH, CPH ; Monica Farley, MD ; Leslie Tengelsen, PhD, DVM ; Meghan Harris, MPH, MPA ; Patricia Ryan, MS ; Craig Morin, MPH ; Ruth Lynfield, MD ; Emily Hancock, MS ; Shelley M. Zansky, PhD ; Brian Fowler, MPH ; Kristy Bradley, DVM, MPH ; Ann Thomas, MD, MPH ; Ananda Bandyopadhyay, MBBS, MPH ; Vickie Horan ; William Shaffner ; Mary Lou Lindegren ; Alicia Fry, MD, MPH

888

Clinical Outcomes of Patients with Diabetes Mellitus Hospitalized with Community-Acquired Pneumonia: Results from the Community-Acquired Pneumonia Organization (CAPO) International Cohort Study
Ruby Gupta, MD ; Hadi Harati, MD ; Patricia Fernandez, MD ; Patricio Jimenez, MD ; Paula Peyrani, MD ; Timothy L. Wiemken, PhD, MPH, CIC ; Steve Burdettte, MD ; Phillip Schuetz, MD ; Sebastian Haubitz, MD ; Julio Ramirez, MD ; Jose Bordon, MD, PhD

889

Outpatient Proton Pump Inhibitor Therapy and Risk of Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis
Trevor Crowell, MD ; Jennifer Lam, MPH ; Cesar Ugarte-Gil, MD, MSc ; Julie Paik, MD ; M. Bradley Drummond, MD, MHS ; Allison Lambert, MD

Posters

Crowell IDWeek Poster.pdf (247.5 kB)

890

Antimicrobial Activity of Ceftaroline Tested against Contemporary (2012) Bacteria Isolated from Community-Acquired Respiratory Tract Infections (CARTI), Including Oxacillin-resistant S. aureus (MRSA)
Helio Sader ; Robert Flamm ; Ronald Jones, MD

Posters

IDWEEK 2013 Ceftaroline CARTI 890.pdf (100.2 kB)

891	Does Bacterial Infection Cause Post-Obstructive Pneumonia (POP)? Daniel Musher, MD, FIDSA ; Rahul Sampath, MD ; Carlo Zuno, MD ; Michael Abers, MD ; Barcleigh Sandvall, MD ; Nancy Logan ; Charles Stager, PhD

892

Burden of Community Acquired Pneumonia and Invasive Pneumococcal Disease amongst Hospitalized Canadian Adults: A Public Health Agency of Canada/Canadian Institutes of Health Research (PCIRN) Serious Outcomes Surveillance Network Study
Shelly Mcneil, MD, FIDSA ; Ardith Ambrose, RN ; Melissa Andrew, MD, PhD ; Guy Boivin, MD ; William Bowie, MD, FRCPC ; May Elsherif, MD ; Karen Green, MSc ; Todd Hatchette, MD ; Jennie Johnstone, MD ; Jason Leblanc, PhD ; Mark Loeb, MD, MSc ; Donna Mackinnon-Cameron, MMath ; Thomas Marrie, MD ; Anne Mccarthy, MD, MSc ; Allison McGeer, MD, MSc, FRCPC, FSHEA ; Makeda Semret, MD ; Grant Stiver, MD ; Sylvie Trottier, MD ; Louis Valiquette, MD, MSc ; Hongyue Wang, MSc ; Duncan Webster, MD ; Lingyun Ye, PhD

893	Antimicrobial Activity of Ceftaroline Tested against Multidrug-Resistant (MDR) Streptococcus pneumoniae in the USA (2009-2012) Robert Flamm ; Helio Sader ; Ronald Jones, MD Posters IDWEEK 2013 Ceftaroline R Subsets 893.pdf (88.6 kB)

894

Treating Healthcare-Associated Pneumonia (HCAP) Requires Therapy Against P. aeruginosa and Methicillin-resistant S. aureus (MRSA)
Stephen Vickery, PharmD ; Johnson James, PharmD ; James Beardsley, PharmD ; John Williamson, PharmD ; Christopher Ohl, MD ; Vera Luther, MD

Posters

HCAP poster idweek13 894.pdf (289.9 kB)

895

Macrolide Immunomodulation and Clinical Outcomes in Hospitalized Patients with Community-Acquired Pneumonia
Forest W. Arnold, DO, MSc ; Julio A. Ramirez, MD ; Rafael Fernandez-Botran, PhD ; Madhavi Rane, PhD ; Silvia Uriarte, PhD ; Robert Kelley, PhD ; Timothy L. Wiemken, PhD, MPH, CIC ; Paula Peyrani, MD ; Jose Bordon, MD, PhD

Posters

RL_IDSA_2013_CAPISG_Arnold.pdf (240.0 kB)

896	Experience with Legionella Pneumonia during a County Wide Outbreak Ami Patel, MD ; Eliahu Bishburg, MD ; Monica Shah, Pharm D ; Nelson Airewele, MD ; Christian Engell, MD Posters Patel Ami - Legionella Pneumonia - research_abstract_poster_template v4.pdf (357.4 kB)

898

Influenza-like illness, the time to seek health care, and influenza antiviral receipt among adults at high risk for influenza complications during the 2010�11 influenza season � United States
Matthew Biggerstaff, MPH ; Michael A. Jhung, MD, MPH ; Carrie Reed, DSc, MPH ; Alicia Fry, MD, MPH ; Lina Balluz, ScD, MPH ; Lyn Finelli, DrPH, MS

899

Incidence of Community-acquired Pneumonia (CAP) Hospitalizations among Children and Adults in the United States: Data from the CDC Etiology of Pneumonia in the Community (EPIC) Study
Seema Jain, MD ; Sandra R. Arnold, MD ; Derek J. Williams, MD, MPH ; Krow Ampofo, MD ; Wesley H. Self, MD, MPH ; Christopher Trabue, MD ; Robert Balk, MD ; Sherene Fakhran, MD, MPH ; Anna M. Bramley, MPH ; Carrie Reed, DSc, MPH ; Evan J. Anderson, MD ; Carlos G. Grijalva, MD, MPH ; Yuwei Zhu, MD, MS ; Chris Stockmann, MSc ; Robert A. Kaufman, MD ; Anami Patel, PhD ; Weston Hymas, MS, MB(ASCP) ; James D. Chappell, MD, PhD ; Chao Qi, PhD ; Mark Courtney, MD ; David Hillyard, MD ; Dean Erdman, Dr PH ; Jonas M. Winchell, PhD ; Maria Da Gloria Carvalho, PhD ; Stephen Lindstrom, PhD ; Matthew Moore, MD, MPH ; Eileen Schneider, MD, MPH ; Lauri Hicks, DO ; Andrew Pavia, MD, FIDSA, FSHEA ; Jonathan A. Mccullers, MD ; Richard G. Wunderink, MD ; Kathryn Edwards, MD, FIDSA ; Lyn Finelli, DrPH, MS

Posters

Jain_EPIC_Incidence_IDSA_2013_final.pdf (277.7 kB)

900

Influenza and other viral infections in outpatients with medically attended acute respiratory illness during the 2011-12 influenza season
Richard Zimmerman, MD MPH ; Charles R. Rinaldo, PhD ; Mary Patricia Nowalk, PhD ; Balasubramani GK, PhD ; Mark Thompson, PhD ; Krissy Moehling, MPH ; Stephen Wisniewski, PhD

901

Outcomes of Guideline-Concordant Therapy for Healthcare Associated Pneumonia
Sarah Haessler, MD ; Michael Rothberg, MD, MPH ; Penelope Pekow, PhD ; Aruna Priya, MA, MSc ; Marya D. Zilberberg, MD, MPH ; Raquel Belforti, DO ; Daniel Skiest, MD ; Tara Lagu, MD, MPH ; Thomas Higgins, MD ; Peter Lindenauer, MD, MSc

Posters

IDWeek2013 poster final.gif (454.8 kB)

902

Development of the Patient-Reported Outcome (PRO) Instrument FLU-PRO to Standardize and Quantify Symptoms of Influenza
John H. Powers III, MD, FIDSA ; Sonja Stringer, MPH ; Sarah Clifford, PhD ; Katherine Kim, MPH ; John Arnold, MD ; Christina Schofield, MD FACP ; Patrick Danaher, MD ; Karl Kronmann, MD, MPH ; Mary Fairchok, MD ; Michael Rajnik, MD ; Erin McDonough, BS ; Deepika Mor, MS ; M Lourdes Guerrero, MD ; Guillermo Ruiz-Palacios, MD ; Andr�s Hern�ndez, MD, MS ; Patricia Rodriguez Zulueta ; Arturo Galindo-Fraga, MD, MS ; Nancy Kline Leidy, PhD ; Eugene Millar, PhD ; Timothy Burgess, MD, MPH ; Michelande Ridore, BA ; Mark Kortepeter, MD, MPH

Posters

FLU PRO Poster 6x4 IDSA FINAL_9-24-2013.pdf (1.8 MB)

903

Etiology of Community-Acquired Pneumonia in Iceland, a One Year Population-Based Prospective Study
Agnar Bjarnason, MD ; Johan Westin, MD, PhD ; Magnus Lindh, MD, PhD ; Lars-Magnus Andersson, MD, PhD ; Karl G. Kristinsson, MD, PhD ; Arthur L�ve, MD, PhD ; Olafur Baldursson, MD, PhD ; Magnus Gottfredsson, MD, PhD

904	Outpatient Antibiotic Prescribing for Community Acquired Pneumonia in the United States from 2001 to 2010 Besu F. Teshome, PharmD ; Grace C. Lee, PharmD ; Kelly R. Daniels, PharmD ; Christopher R. Frei, PharmD, MSc

905	Trends in Hospitalizations for Pneumonia in the United States, 2002-2010 Brandon Wuerth, BS ; John Bonnewell, BA ; Forest Arnold, DO Posters Pneumonia_Poster_round_10.png (1.3 MB)

906	Impact on Patient Outcomes of Pan-Resistant Acinetobacter baumannii Ventilator-Associated Pneumonia Elif Sahin Horasan, MD ; Eylem Sercan Ozg�r ; Kerem Karaca ; Sibel Atis Nayci ; G�lden Ers�z ; Ali Kaya Posters idweek2013act.pdf (1001.8 kB)

907	Treatment of Severe Community Acquired Pneumonia with Vancomycin and Levofloxacin: A Retrospective Review Dan Fulton, MD ; Margaret Simpson, MD

908	Risk factors for Inappropriate Treatment of Community-Acquired Pneumonia in the Emergency Department Scott Micek, PharmD ; Adam Lang, BS ; Nicholas Hampton, PharmD ; Marin Kollef, MD

909	Antimicrobial Prescriptions for Veterans Affairs (VA) Influenza-Coded Encounters and Patients Tested for Influenza Patricia Schirmer, MD ; Russell Ryono, Pharm. D. ; Cynthia Lucero-Obusan, MD ; Renee-Claude Mercier, Pharm.D. ; Carla Winston, PhD ; Gina Oda, MS ; Mark Holodniy, MD

910	Inhaled Colistin as Treatment for Patients With Multidrug Resistant Gram Negative Bacterial Pneumonia and Tracheobronchitis Diala Faddoul, MD ; Michael Ta, BS ; Melanie George ; Pia Pannaraj, MD, MPH

911

Risk factors for prognosis and influence of mucA gene mutation in patients with Pseudomonas aeruginosa pneumonia
Su Jin Jeong, MD/PhD ; Kang-Mu Lee, PhD ; Jin Young Ahn, MD ; Je Eun Song, M.D. ; Min Hyung Kim, M.D. ; Sun Bean Kim, MD ; Nam Su Ku, MD ; Sang Hoon Han, MD ; Jun Yong Choi, MD, PhD ; Dongeun Yong, MD, PhD ; Sang Sun Yoon, PhD ; June Myung Kim, MD ; Kyungwon Lee, MD, PhD

912	Viral Infection as Risk Factor for Acute Lung Injury after Elective Cardiac Surgery Geert H. Groeneveld, MD ; Judith Van Paassen ; Ann C.T.M. Vossen, MD ; M. Sesmu Arbous ; J.T. Van Dissel, MD, PhD Posters Poster 3 IDSA Viral Infection as Risk Factor for Acute Lung.pdf (220.9 kB)

913

Analysis of Time to Being Dischargeable in Hospitalized Patients with Community Acquired Pneumonia (CAP) Using Data from the FOCUS Trials
Thomas Lodise, PharmD ; Antonio R Anzueto, MD ; Andrew F. Shorr, MD, MPH ; David J. Weber, MD, MPH, FIDSA, FSHEA ; Min Yang, MD, PhD ; Alexander Smith, MS ; Qi Zhao, MD, MPH ; Xing-Yue Huang, BPharm, PhD ; Thomas M. File Jr., MD, MSc, MACP, FIDSA, FCCP

Posters

Forest - Time-to-Being Dischargeable in Hospitalized CAP Patients Using FOCUS Trials_IDWeek.pdf (742.3 kB)

914

Statin Use and Hospital Length of Stay in Adults Hospitalized with Community-Acquired Pneumonia (CAP) in the CDC Etiology of Pneumonia in the Community (EPIC) Study
Fiona Havers, MD, MHS ; Anna M. Bramley, MPH ; Carrie Reed, DSc, MPH ; Lyn Finelli, DrPH, MS ; Wesley H. Self, MD, MPH ; Christopher Trabue, MD ; Sherene Fakhran, MD, MPH ; Robert Balk, MD ; Mark Courtney, MD ; Timothy Girard, MD, MSCI ; Evan J. Anderson, MD ; Carlos G. Grijalva, MD, MPH ; Kathryn Edwards, MD, FIDSA ; Richard G. Wunderink, MD ; Seema Jain, MD

Posters

EPIC Statin IDWeek poster final.pdf (582.0 kB)

915

Relationship between Time to Clinical Response and Outcomes among PORT III and IV Patients (Pts) with Community-Acquired Bacterial Pneumonia (CABP)
Evan Zasowski, PharmD ; Jill Butterfield, PharmD ; Louise-Anne Mcnutt, PhD ; Jason Cohen, DO ; Leon Cosler, PhD ; Joseph Gottwald ; Wen-Zhen Chen ; Thomas Lodise, PharmD

916

Antimicrobial Susceptibility Observed Among Gram-Negative Pathogens, a Longitudinal Analysis from Patient Isolates in the United States; TEST Program 2004-2012
Douglas Biedenbach, BS ; Meredith Hackel, PhD ; Samuel Bouchillon, MD ; Daryl Hoban, PhD ; Robert Badal, BS ; Heidi Leister-Tebbe, BS

Posters

IDSA 916.pdf (682.0 kB)

917

Polymerase Chain Reaction (PCR) Improves Pathogen Identification from Pleural Fluid of Children and Adults hospitalized with Community Acquired Pneumonia (CAP): Preliminary Results from the Etiology of Pneumonia in the Community (EPIC) Study
Krow Ampofo, MD ; Chris Stockmann, MSc ; Anne Blaschke, MD, PhD ; Maria Da Gloria Carvalho, PhD ; Anna M. Bramley, MPH ; Derek J. Williams, MD, MPH ; Wesley H. Self, MD, MPH ; Kathryn Edwards, MD, FIDSA ; Carlos G. Grijalva, MD, MPH ; Yuwei Zhu, MD, MS ; Evan J. Anderson, MD ; Richard G. Wunderink, MD ; Mark Courtney, MD ; Chao Qi, PhD ; Sandra Arnold, MD ; Jonathan A. Mccullers, MD ; Lauri Hicks, DO ; Dean Erdman, Dr PH ; Adam L. Hersh, MD, PhD ; Carrie L. Byington, MD ; Seema Jain, MD ; Andrew Pavia, MD, FIDSA, FSHEA

Posters

IDSA Poster (PPE) -- 30September2013.pdf (1.0 MB)

918	Use of FilmArray� Respiratory Panel Test for Diagnosis of Influenza Like Illness in Immunocompromised Patients Amanda Guedes De Morais, M.D. ; Sherif Mossad, MD ; Nabin Shrestha, MD, MPH, FIDSA ; Debra Kohn, MT(ASCP) ; Belinda Yen-Lieberman, Ph.D. Posters Film array final poster.pdf (455.2 kB)

919	Clinical Evaluation of Influenza A Rapid Antigen Assay During 2012-2013 Season Catherine D. Bacheller, MD ; Carol Quinter, PhD ; Krista Snapp, MLS (ASCP) Posters 919_IDWposter.pdf (1.0 MB)

920	Age Specific Prevalence of Influenza A Positive with Bacterial Co-detection during the 2012-2013 Influenza Season Elena Grigorenko, PhD ; Donald Stalons, MPH, PhD, D(ABMM) Posters 920_IDWposter.pdf (1.3 MB)

921	Clinical and Epidemiological Characteristics of Serotype 6D Pneumococcal Infections Joon Young Song, MD ; Moon H. Nahm, MD ; Tae Un Yang, MD ; Kyung-Wook Hong, MD ; Hee Jin Cheong, MD ; Woo Joo Kim, MD

922	Impact of a multiplex PCR-based testing system on the management of severe nosocomial pneumonia Vincent Rotimi, MD, PhD ; Ebtehal Al Roomi, MD ; Lubna Abdulaziz, BSc ; Wafaa Jamal, MD, PhD

923	Respiratory Manifestations of Scrub Typhus: A Study in a Teaching Hospital from South India Sakshi Sadhu, MBBS ; Danturulu Muralidhar Varma, MD ; Sudha Vidyasagar, MD ; Sagarika Nanda, MD

924	Adverse Maternal Outcomes Following Influenza Infection and Vaccination During Pregnancy Stephanie Irving, MHS ; De-Kun Li, MD, PhD ; Sarah Ball, MPH, ScD ; Allison Naleway, PhD Posters 924_Irving_Poster.pdf (311.3 kB)

925

Serotype Distribution of Streptococcus pneumoniae Recovered Principally from Non-sterile Sites in Patients Aged �18 years in the US (2009-2011)
Rosalind C Hollingsworth, PHD ; Rodrigo E Mendes, PHD ; Andrew J Costello ; Dial Hewlett Jr., MD ; Ronald Jones, MD ; Raul E Isturiz, MD

Posters

Prevenar 13v_Hollingsworth_2013 IDWeek.pdf (485.6 kB)

926

Streptococcus pneumoniae Serotype 3 Recovered Predominantly from Non-sterile Sites in Patients Aged ≥18 Years in the USA (2009-2011)
Dial Hewlett Jr., MD ; Rosalind C Hollingsworth, PHD ; Rodrigo E. Mendes, Ph.D. ; Andrew J Costello ; Ronald Jones, MD ; Raul E Isturiz, MD

Posters

Prevenar 13v_Hewlett_2013 IDWeek.pdf (486.5 kB)

927	Impact of respiratory viral infections on the serotype distribution of pneumococcal pneumonia Joon Young Song, MD ; Moon H. Nahm, MD ; Tae Un Yang, MD ; Kyung-Wook Hong, MD ; Hee Jin Cheong, MD ; Woo Joo Kim, MD

928	Serotypes of Invasive and Non-Invasive Pneumococcal Infections in Adults in Portugal Were Different Before PCV7 Effect Andreia N. Hor�cio ; Mario Ramirez, PhD ; Jose Melo-Cristino, MD, PhD

929	Safety and Tolerability of Aerosolized Voriconazole Timothy J. Jancel, PharmD ; Alexandra F. Freeman, MD ; Steven Holland, MD ; Kenneth Olivier, MD, MPH

930

Self-reported Severity and Impact of Laboratory-confirmed Influenza and Non-influenza Acute Respiratory Illness Among Healthcare Personnel, 2010-11
Stephanie Irving, MHS ; Emily Henkle, PhD, MPH ; Manjusha Gaglani, MBBS ; Sarah Ball, MPH, ScD ; Mark Thompson, PhD ; Allison Naleway, PhD

Posters

930_Irving_Poster.pdf (543.0 kB)

931

Knowledge of Healthcare Personnel about Appropriate Personal Protective Equipment in Outpatient Healthcare Settings
Kelly Haines, MSW, MPH ; Laura Chopko, BA ; Martha Zorn, MS ; Mary Bessesen, MD ; Ann-Christine Nyquist, MD, MSPH ; Trish M. Perl, MD, MSc, FIDSA, FSHEA ; Connie Price, MD ; Lewis Radonovich, MD ; Nicholas G Reich, PhD ; Maria C. Rodriguez-Barradas, MD ; Michael Simberkoff, MD ; Cynthia Gibert, MD, MSc

Posters

Abstract 42512 Knowledge of HCP appropriate PPE outpatient settings.pdf (819.2 kB)

932	Guideline Compliance for Hospital-Acquired, Ventilator-Associated, and Health-Care Associated Pneumonia Asaf Shor, MD, MPH ; Timothy Jenkins, MD ; Michelle Haas, MD ; Bryan Knepper, MPH, MSc ; Connie Price, MD Posters IDSA_HCAP_guideline_validation.png (3.7 MB)

933	Comparison of Susceptibility Patterns for Gram-Negative Pathogens among Upper and Lower Respiratory Sources of Infection; TEST 2004-2012 Samuel Bouchillon, MD ; Ian Morrissey, PhD ; Daryl Hoban, PhD ; Brian Johnson, BS ; Heidi Leister-Tebbe, BS Posters IDSA 933.pdf (598.7 kB)

934

Predictors of Poor Outcomes in Patients with Methicillin-resistant Staphylococcus aureus (MRSA) Pneumonia
Jennifer Mcdanel, MS ; Eli Perencevich, MD, MS, FIDSA, FSHEA ; Daniel J. Diekema, MD, FIDSA, FSHEA ; Patricia Winokur, MD ; Jennifer Johnson, PhD ; Loreen A. Herwaldt, MD, FIDSA, FSHEA ; Tara Smith, PhD ; Elizabeth Chrischilles, PhD ; Jeffrey Dawson, ScD ; Marin Schweizer, PhD

935	Ventilator-Associated Infections Due to Staphylococcus aureus: Incidence, Treatment and Outcomes Mohamed Ben Omran, MD ; Yuxiu Lei, Ph.D ; Donald Craven, MD, FIDSA ; Jana Hudcova, MD Posters IDSA 2013 Final.pdf (556.0 kB)

936	Mycoplasma pneumoniae infection associated with ICU admission: common or emerging disease manifestation? Tawfik Khoury ; Adi Nubani ; Avraham Abutbul ; Sara Hoss ; Sigal Sviri ; Abed El-Raouf Bayya ; Carlos Hidalgo-Grass ; Allon E. Moses ; Ran Nir-Paz Posters IDSA poster 936.pdf (694.8 kB)

937

Age-Specific Incidence of Parainfluenza Viruses Among Outpatients in the United States:� The Influenza Incidence Surveillance Project, 2010-2013
Andrea Giorgi, MPH ; Elizabeth Bancroft, MD SM ; Steve Di Lonardo, MS ; Jose Lojo, MPH ; Jonathan Temte, MD, PhD ; Ruth Lynfield, MD ; Oluwakemi Oni, MPH ; Brett L. Whitaker, MS ; Glen Abedi, MPH ; Dean Erdman, Dr PH ; Lyn Finelli, DrPH, MS ; Ashley Fowlkes, MPH

938

Rates of Pediatric Hospital and Intensive Care Unit Admissions for Lower Respiratory Tract Infections from MarketScan Data � United States, 2007-2011
Adena Greenbaum, MD, MPH ; Jufu Chen, PhD ; Carrie Reed, DSc, MPH ; Suzanne Beavers, MD ; David Callahan, MD ; Lyn Finelli, DrPH, MS ; Alicia Fry, MD, MPH

Posters

Marketscan IDSA poster_9_23_final[2].pdf (459.8 kB)

939

Ventilator-associated pneumonia caused by Stenotrophomonas maltophilia in pediatric patients
Byung-Kee Lee, MD ; Joong Bum Cho, MD ; Soo Jin Kim, MD ; Soo-Han Choi, MD ; Kang-Mo Ahn, MD, PhD ; Hong Eo, MD, PhD ; So-Young Yoo, MD, PhD ; Ji Hye Kim, MD, PhD ; Nam Yong Lee, MD, PhD ; Yae-Jean Kim, MD, PhD

940

Provider Awareness and Altered Practice Following a 2011-2012 Bordetella pertussis Outbreak, New York City
Robert Arciuolo, MPH, CPH ; Jennifer Rosen, MD ; Jane Zucker, MD, MSc

Posters

940. Provider Awareness and Altered Practice Following a 2011-2012 Bordetella pertussis Outbreak, New York City.pdf (600.2 kB)

942	In-Hospital Administration of Palivizumab in Children Neika Vendetti, MPH ; Jeffrey S. Gerber, MD, PhD ; Julia Shaklee Sammons, MD, MSCE ; Brian Fisher, DO, MPH, MSCE ; Theoklis Zaoutis, MD, MSCE ; Susan E. Coffin, MD, MPH

943	Poor Positive Predictive Value of Influenza-like Illness (ILI) Criteria in Adult Transplant Patients Jonathan Claus, MD ; Aimee Hodowanec, MD ; Kamaljit Singh, MD Posters IDSAposter_Final.pdf (1.6 MB)

944

Post-hospitalization impact of influenza on community-dwelling older adults
Sandra S. Chaves, MD, MSc ; Alejandro Perez, MPH ; Tiffany D'mello, MPH, MBA ; Lisa Miller, MD ; Nancy M. Bennett, MD ; Ananda Bandyopadhyay, MBBS, MPH ; Monica M. Farley, MD ; Brian Fowler, MPH ; Emily B. Hancock, MS ; Pam Daily Kirley, MPH ; Ruth Lynfield, MD ; Patricia Ryan, MS ; Craig Morin, MPH ; William Schaffner, MD ; Ruta Sharangpani, MD, MPH ; Mary Lou Lindegren ; Leslie Tengelsen, PhD, DVM ; Ann Thomas, MD, MPH ; Mary Hill, MPH ; Kristy Bradley, DVM, MPH ; James Meek, MPH ; Shelley M. Zansky, PhD ; Lyn Finelli, DrPH, MS

Posters

Post-hospitalization influenza impact_IDWeek_2013_SSChaves.pdf (481.6 kB)

945	Laboratory-Confirmed Influenza-Related Hospitalizations in New Mexico, 2008�2012 Emily B. Hancock, MS ; Melissa R. Pfeiffer, MPH ; Joan Baumbach, MD, MPH, MS Posters IDWeekPoster_Hancock_FINAL_19August2013.pdf (212.2 kB)